Stocks

“Penny Stock Aerpio Pharmaceuticals’ Merger With Aadi Makes It A Buy, Says Analyst”

“Aerpio Pharmaceuticals (ARPO) is a biopharmaceutical company focused on developing compounds that activate Tie2. Tie2 is considered a key regulator of vascular stability, and ARPO “believes that activation of Tie2 may have therapeutic potential” for different indications. In Q1, ARPO… Continue Reading…

Stocks

“3 Under the Radar Penny Stocks With Triple-Digit Gains in Sight”

“BioHiTech Global, Inc. (BHTG)… In line with these comments, Dayal rates the stock as a Buy, and his $4 price target implies robust growth of 181% for the next 12 months. Dayal’s review is the only one file for BHTG shares,… Continue Reading…

Stocks

“10 great stocks to own because oil prices have surged: Goldman Sachs”

“Mehta outlined 10 oil stocks he is bullish on in a new piece of research on Tuesday: (1) Occidental Petroleum (OCY); (2) ExxonMobil (XOM); (3) Ovintiv (OVV); (4) Diamondback Energy (FANG); (5) ConocoPhillips (COP); (6) EQT Corporation (EQT); (7) Pioneer… Continue Reading…

Economy, Stocks

“S&P 500 hits another record high after better-than-expected June jobs report”

“Futures contracts tied to the major U.S. stock indexes rose slightly on Friday as the June jobs report beat expectations, putting Wall Street on track to post a solid week of gains across the board. Contracts tied to the Dow… Continue Reading…

Business, Stocks

“Who gets the $12.6M in restitution from the Robinhood settlement”

“On Wednesday, Robinhood reached a settlement with FINRA over a multitude of issues, agreeing to pay a fine of $57 million and restitution to customers of $12.6 million. In the 122-page settlement document against Robinhood, FINRA explains that the company “has paid or intends… Continue Reading…

Stocks

“General Electric stock could potentially double: Goldman Sachs”

“…”We view GE as the ultimate self-help, re-opening levered story in Industrials,” said Goldman Sachs analyst Joe Ritchie in a new research note on Tuesday. The analyst slapped a $16 price target on GE’s stock, representing about a 22% upside… Continue Reading…

Stocks

“May home sales rebound to highest level since 2005, shocking even the Realtors”

“Pending home sales, a measure of signed contracts on existing homes, jumped an unexpectedly high 8% in May compared with April, according to the National Association of Realtors. Analysts expected a 1% drop. This is the highest level of sales… Continue Reading…

Stocks

“JPMorgan: These 3 Stocks Could Spike at Least 70% From Current Levels”

“Day One Biopharmaceuticals (DAWN)… Overall, there is broad agreement on Wall Street with Rama’s view, as indicated by the unanimous Strong Buy consensus rating, supported by 4 recent positive reviews. Shares in DAWN are selling for $20.11 and their $37.33 average… Continue Reading…

Stocks

“NIO Stock Is Going Nuts. This Is the Best Explanation.”

“NIO (ticker: NIO) stock gained almost 10% Monday and shares are up 28% over the past month. The S&P 500, for comparison, rose 0.2% Monday and is up 2% over the past month. Call options volume, which rose almost 200% on Monday… Continue Reading…

Stocks

“Intellia Stock Could Surge 35-45% After Positive Gene Editing Data, Says Analyst”

“On Saturday, the company released interim data from the Phase 1 trial of its collaboration with Regeneron on an experimental therapy for transthyretin amyloidosis (ATTR) – a protein misfolding disorder… While it is still early days, Issi calls the data… Continue Reading…